Amidopropoxyphenyl orexin receptor antagonists

Details for Australian Patent Application No. 2006235302 (hide)

Owner Merck & Co., Inc.

Inventors Schreier, John; Coleman, Paul J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006235302

PCT Pub. Number WO2006/110626

Priority 60/718,340 19.09.05 US; 60/670,542 12.04.05 US

Filing date 10 April 2006

Wipo publication date 19 October 2006

International Classifications

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110626 Priority application(s): WO2006/110626

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235307-Methods of use of orally administered probiotic Bifidobacteria for human beauty benefits

2006235297-Temporary ENUM gateway